8-K
filed September 28, 2023, 7:59 PM ET
ticker SONM
CIK 0001178697
other material
confidence high
sentiment neutral
materiality 0.60
Sonim shareholders approve 2M-share increase to 2019 equity plan
DNA X, Inc.
- Shareholders approved amendment to 2019 Equity Incentive Plan to add 2,000,000 authorized shares (21,214,229 for, 2,361,341 against).
- Total share reserve under the plan now 11,003,242, plus automatic annual evergreen increases through 2029.
- All five director nominees (Cassano, Liu, Mulica, Steenstra, Wang) elected at annual meeting.
- Plan amendment effective September 28, 2023; enables continued equity grants to employees, directors, and consultants.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
DNA X, Inc. shareholders approved Election of five director nominees to the Board of Directors at the 2023-09-28 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-09-28
Exact text from the filing
The Annual Meeting was held on September 28, 2023. Holders of 30,394,319 shares of the Company’s common stock were represented at the meeting in person or by proxy, constituting a quorum. The following are the voting results on each matter submitted to the stockholders of the Company at the Annual Meeting. Proposal 1: The stockholders elected each of the five director nominees to the Board of Directors of the Company to serve until the next annual meeting and until his or her successor has been duly elected and qualified, as follows: Name Votes Withheld Broker Non-Votes James Cassano 22,559,091 1,040,013 6,795,215 Peter Liu 23,452,354 153,953 6,788,012 Mike Mulica 21,565,460 2,040,805 6,788,054 Jack Steenstra 21,547,809 2,051,253 6,795,257 Jeffrey Wang 23,399,954 206,353 6,788,012
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
DNA X, Inc. shareholders approved Approval of amendment to the Plan to increase aggregate number of shares of common stock authorized for issuance by 2,000,000 shares at the 2023-09-28 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-09-28
Exact text from the filing
Proposal 3: The stockholders approved an amendment to the Plan to increase the aggregate number of shares of common stock authorized for issuance by 2,000,000 shares, as follows: Votes Against Votes Abstained Broker Non-Votes 21,214,229 2,361,341 30,737 6,788,012
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
DNA X, Inc. shareholders approved Ratification of appointment of Moss Adams LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-09-28 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-09-28
Exact text from the filing
Proposal 2: The stockholders, on an advisory basis, ratified the appointment of Moss Adams LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, as follows: Votes Against Votes Abstained Broker Non-Votes 30,231,684 137,903 24,732 N/A
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.